Immune evasion as a pathogenic mechanism of varicella zoster virus
about
CD4 T cell immunity is critical for the control of simian varicella virus infection in a nonhuman primate model of VZV infection.Incidence of herpes zoster in patients with giant cell arteritis: a population-based cohort study.Identification of an important immunological difference between virulent varicella-zoster virus and its avirulent vaccine: viral disruption of dendritic cell instructionDistinct domains in the adenovirus E3 RIDalpha protein are required for degradation of Fas and the epidermal growth factor receptor.Attenuation of the adaptive immune response in rhesus macaques infected with simian varicella virus lacking open reading frame 61.CD4 T cell responses in latent and chronic viral infections.Influence of systemic immune and cytokine responses during the acute phase of zoster on the development of postherpetic neuralgia.Cytomegalovirus and varicella-zoster virus vaccines in hematopoietic stem cell transplantation.Varicella zoster virus immune evasion strategies.Further characterization of a rat model of varicella zoster virus-associated pain: Relationship between mechanical hypersensitivity and anxiety-related behavior, and the influence of analgesic drugsVaricella zoster virus glycoprotein E-specific CD4+ T cells show evidence of recent activation and effector differentiation, consistent with frequent exposure to replicative cycle antigens in healthy immune donors.Varicella-Zoster Virus Activates CREB, and Inhibition of the pCREB-p300/CBP Interaction Inhibits Viral Replication In Vitro and Skin Pathogenesis In Vivo.Targeted dermal delivery of highly potent anti-varicella zoster virus nucleoside analogues from saturated solutions and ethanolic oil-in-water creams.Enhancement of cutaneous immunity during ageing by blocking p38 MAPkinase induced inflammation.
P2860
Q34079162-9F7C1643-6D05-4D74-B653-51B065FD1D2BQ34308422-5CC97CB2-80AD-4CD5-B6E2-A2734F09839DQ34549746-FA4C5944-C932-4C31-AE45-973643E866D6Q36541174-602B0DED-9C93-402F-B9FD-BCB8AC441BDAQ36607327-821FEC18-364F-4311-8A43-486578E11BB4Q36837631-65F955AA-5ABC-4B11-BBF6-08E8E6F75319Q37294253-D0549181-9465-452C-98EE-F514CEB736D0Q37559627-8C4BC1C5-205B-4543-BBEF-8F30B2A6090BQ37606051-84741E6F-0F1F-4D20-A4C6-94590156827FQ38603800-E8D0971B-BDD8-44B5-BA89-E32FCFB9337BQ39998958-8D97EF4E-1ABA-40D0-8644-82639E2236B8Q40605506-9F1F6CB6-525D-4520-97ED-6CB02EB715B5Q44941810-50E700D1-97F5-49B9-A685-333C82229139Q47385612-05CB5576-BE85-4781-A2B0-B59B15C541E6
P2860
Immune evasion as a pathogenic mechanism of varicella zoster virus
description
2001 nî lūn-bûn
@nan
2001 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
Immune evasion as a pathogenic mechanism of varicella zoster virus
@ast
Immune evasion as a pathogenic mechanism of varicella zoster virus
@en
Immune evasion as a pathogenic mechanism of varicella zoster virus
@nl
type
label
Immune evasion as a pathogenic mechanism of varicella zoster virus
@ast
Immune evasion as a pathogenic mechanism of varicella zoster virus
@en
Immune evasion as a pathogenic mechanism of varicella zoster virus
@nl
prefLabel
Immune evasion as a pathogenic mechanism of varicella zoster virus
@ast
Immune evasion as a pathogenic mechanism of varicella zoster virus
@en
Immune evasion as a pathogenic mechanism of varicella zoster virus
@nl
P356
P1476
Immune evasion as a pathogenic mechanism of varicella zoster virus
@en
P2093
Allison Abendroth
Ann M. Arvin
P356
10.1006/SMIM.2001.0293
P577
2001-02-01T00:00:00Z